MAPT and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease studies, L-NBP has been shown to improve synaptic functions; reduce Aβ plaque load, oxidative stress, and microglia activation; and inhibit abnormal tau hyperphosphorylation, which plays a role in the Aβ tau synergy [45].